The MD Magazine Diabetes condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

The Enormous Cost of Non-Alcoholic Fatty Liver Disease
A new study examined the cost of increasingly prevalent non-alcoholic fatty liver disease in both the United States and Europe and places the bill in the hundreds of billions.
Peter A. McCullough, MD, and Nicolaas Deutz, MD, PhD, highlight the role of amino acids, protein, and B-hydroxy B-methylbutyrate in rebuilding muscle mass for patients with sarcopenia.
Nicolaas Deutz, MD, PhD, and Peter A. McCullough, MD, discuss the importance of the role of protein in treating malnutrition and sarcopenia.
One year after beginning Lucentis treatment for diabetic macular edema, the group who had a decrease in visual acuity also had the greatest decrease in HbA1c level.
Recent trials involving promising medications to treat patients with heart failure with preserved ejection fraction have not produced significant reductions in mortality.
The FDA approved a fixed-dose combination of canagliflozin and metformin hydrochloride extended release (Invokamet RX/Janssen).
Subcutaneously administered furosemide yields nearly identical outcomes compared with the traditional intravenous method of delivery, but is more convenient and well tolerated.
Higher levels of nitrogen dioxide were associated with higher levels of HOMA-IR, glucose, insulin, and leptin. The degree of association, however, varied among the different populations. Effect estimates for pre-diabetic individuals were large and highly statistically significant, while the associations were smaller and weaker in non-diabetic individuals and those who had already developed T2DM.
For those with type 2 diabetes who reside in rural communities, distance from large medical centers and research universities may limit their access to new ideas and programs. The result may be poorer disease management and less physical activity than is reasonable or necessary. Welcome: mobile apps.

Most Popular


$vacMongoViewPlus$ $vAR$